Holen Sie sich die Stockscreener-App
184.10
2.95%
5.27
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$178.83
Offen:
$178.84
24-Stunden-Volumen:
2.74M
Relative Volume:
1.46
Marktkapitalisierung:
$22.14B
Einnahmen:
$126.36B
Nettoeinkommen (Verlust:
$1.30B
KGV:
17.25
EPS:
10.6697
Netto-Cashflow:
$1.55B
1W Leistung:
-5.07%
1M Leistung:
-32.80%
6M Leistung:
-34.71%
1J Leistung:
-27.20%
1-Tages-Spanne:
$178.41
$184.50
1-Wochen-Bereich:
$169.61
$195.20
52-Wochen-Spanne:
$169.61
$315.35
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
500 W MAIN ST, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
184.10 | 21.51B | 126.36B | 1.30B | 1.55B | 10.67 |
|
UNH
Unitedhealth Group Inc
|
293.19 | 257.59B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
78.48 | 99.14B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
291.44 | 75.77B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
346.80 | 74.17B | 199.13B | 5.66B | 3.17B | 25.11 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
ProShare Advisors LLC Cuts Position in Humana Inc. $HUM - MarketBeat
Caprock Group LLC Takes $2.09 Million Position in Humana Inc. $HUM - MarketBeat
Deal Dispatch: Britney Spears Sells, Humana Eyes MaxHealth, Mercedes Spins Off Stake - Bitget
Deal Dispatch: Britney Spears Sells, Humana Eyes MaxHealth, Mercedes Spins Off Stake - Benzinga
Humana acquires MaxHealth, adds dozens of clinics to CenterWell - Modern Healthcare News
Humana’s Star-Crossed Guidance: Why a Q4 Beat Couldn't Save the Stock from a 2026 Tailspin - The Chronicle-Journal
Humana Buys Clinic Operator MaxHealth From Arsenal Capital - Bloomberg.com
CenterWell Completes Acquisition of MaxHealth From Arsenal Capital Partners - Business Wire
Humana Shares Plunge as $3.5 Billion Star Ratings Headwind Forces Conservative 2026 Guidance - FinancialContent
TD Cowen Maintains Hold Rating on Humana (HUM) Amid Price Target Cut | HUM Stock News - GuruFocus
Goldman Sachs Adjusts Price Target on Humana to $158 From $215, Maintains Sell Rating - marketscreener.com
Humana is said to be near $1B deal for MaxHealth - Modern Healthcare News
Humana Bets On Google Cloud AI To Tackle Costs And Service - simplywall.st
Humana stock rating downgraded by RBC Capital on Medicare Advantage risk - Investing.com Australia
Renderings for proposed Humana Tower renovations highlighted at mayor's State of the City address - WDRB
Humana (HUM) stock rebounds after earnings shock — Star Ratings and Medicare rates now drive the price - Bez Kabli
Balanced Risk-Reward Amid Growth Ambitions and Margin Rebuild Supports Humana Hold Rating - TipRanks
Humana Is Said to Near $1 Billion Deal for Florida’s MaxHealth - Bloomberg.com
Renderings for Humana Tower renovations highlighted at Greenberg's State of the City Address - WDRB
Humana sells Hikes Lane medical office building for $2.5 million - WDRB
Humana sells medical office building on Hikes Lane - WDRB
PHOTOS: First look at new hotel set to replace former Humana tower in downtown Louisville - WHAS11
Jefferies Maintains Buy Rating on Humana (HUM) but Lowers Price Target | HUM Stock News - GuruFocus
Humana (HUM): UBS Lowers Price Target, Maintains Neutral Rating - GuruFocus
Renderings revealed: Humana Building's transformation into 1,000-room hotel - The Business Journals
Mayor Craig Greenberg shares renderings for the Humana Tower’s hotel transformation - WAVE News
PHOTOS: First look at renderings of big Humana Tower renovation - WLKY
RBC Capital Downgrades Humana (HUM): Price Target Slashed | HUM Stock News - GuruFocus
Humana Analysts Slash Their Forecasts After Q4 Results - Benzinga
UBS Adjusts Humana Price Target to $195 From $285, Maintains Neutral Rating - marketscreener.com
Guggenheim Lowers Price Target for Humana (HUM) but Maintains Bu - GuruFocus
Humana's Higher Membership Growth Could Put Medicare Advantage Book at Risk, RBC Says - marketscreener.com
Morgan Stanley Sees Humana’s Earnings Recovery Taking Longer - Finimize
Humana Earnings Recovery Under Threat From Multiple Headwinds, Morgan Stanley Says - marketscreener.com
Cantor Fitzgerald lowers Humana stock price target to $201 from $290 - Investing.com
Oppenheimer Adjusts Humana Price Target to $250 From $310, Maintains Outperform Rating - marketscreener.com
Humana Guides 2026 EPS to $9, Shares Drop 6.5% - GuruFocus
Cantor Fitzgerald Cuts Humana (NYSE:HUM) Price Target to $201.00 - MarketBeat
Evercore ISI Cuts Humana (NYSE:HUM) Price Target to $180.00 - MarketBeat
Leerink Partners Lowers Humana (NYSE:HUM) Price Target to $185.00 - MarketBeat
Humana forecasts 2026 profit pressure as lower quality ratings weigh - MSN
Guggenheim lowers Humana stock price target on Stars headwind concerns By Investing.com - Investing.com India
Humana Inc. (NYSE:HUM) Q4 2025 earnings call transcript - MSN
Guggenheim lowers Humana stock price target on Stars headwind concerns - Investing.com
Humana Inc. (NYSE:HUM) Q4 2025 Earnings Call Transcript - Insider Monkey
HUM Downgraded by RBC Capital Amid Concerns Over Membership Grow - GuruFocus
Morgan Stanley Cuts Price Target on Humana to $146 From $174, Keeps Underweight Rating - marketscreener.com
Leerink Partners Adjusts Price Target on Humana to $185 From $267, Maintains Market Perform Rating - marketscreener.com
Jefferies Adjusts Price Target on Humana to $235 From $310, Maintains Buy Rating - marketscreener.com
RBC Downgrades Humana to Sector Perform From Outperform, Cuts Price Target to $189 From $322 - marketscreener.com
Is Humana Stock Built to Withstand More Downside? - Trefis
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.57%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):